Showing results (1-10 of 88) with videos related to
Sort By:
Pageof 9
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 14, 2019
Tinzaparin Sodium Pharmacokinetics in Patients with Chronic Kidney Disease: Practical ImplicationsHélène Helfer, Virginie Siguret, Isabelle MahéCurrent Opinion in Pulmonary Medicine|August 19, 2004
Low molecular weight heparin treatment in elderly subjects with or without renal insufficiency: new insights between June 2002 and March 2004Virginie Siguret, Eric Pautas, Isabelle GouinCurrent Opinion in Hematology|October 14, 2024
Effects of selective serotonin reuptake inhibitors on platelet functions: a literature reviewAntoine Mokhtarian, Virginie Siguret, Georges JourdiClinical Interventions in Aging|May 12, 2010
A need for evidence-based clinical practice guidelines for the use of heparins in the elderlyIsabelle Gouin-Thibault, Virginie Siguret, Eric PautasDrug Safety|March 24, 2005
Safety profile of different low-molecular weight heparins used at therapeutic doseIsabelle Gouin-Thibault, Eric Pautas, Virginie SiguretVitamins and Hormones|April 1, 2008
Warfarin therapy: influence of pharmacogenetic and environmental factors on the anticoagulant response to warfarinVirginie Siguret, Eric Pautas, Isabelle Gouin-ThibaultFuture Cardiology|October 7, 2009
Vitamin K antagonist use in the elderly: special considerationsVirginie Siguret, Eric Pautas, Isabelle Gouin-ThibaultAnnales De Biologie Clinique|October 11, 2012
[Vitamin K antagonists: from discovery to pharmacogenetics]Caroline Moreau, Marie-Anne Loriot, Virginie SiguretClinical and Translational Science|March 19, 2025
Effect of Selective Serotonin Reuptake Inhibitors on Coagulation: Fact or Fiction?Antoine Mokhtarian, Sophie Melicine, Virginie Siguret, et al.Annales De Biologie Clinique|April 17, 2014
[Management of vitamin K antagonists in the elderly]Tiphaine Belleville, Éric Pautas, Pascale Gaussem, et al.Pageof 9